Quantity and Size Distribution of Cough-Generated Aerosol Particles Produced by Influenza Patients During and After Illness

The question of whether influenza is transmitted to a significant degree by aerosols remains controversial, in part, because little is known about the quantity and size of potentially infectious airborne particles produced by people with influenza. In this study, the size and amount of aerosol particles produced by nine subjects during coughing were measured while they had influenza and after they had recovered, using a laser aerosol particle spectrometer with a size range of 0.35 to 10 μm. Individuals with influenza produce a significantly greater volume of aerosol when ill compared with afterward (p = 0.0143). When the patients had influenza, their average cough aerosol volume was 38.3 picoliters (pL) of particles per cough (SD 43.7); after patients recovered, the average volume was 26.4 pL per cough (SD 45.6). The number of particles produced per cough was also higher when subjects had influenza (average 75,400 particles/cough, SD 97,300) compared with afterward (average 52,200, SD 98,600), although the difference did not reach statistical significance (p = 0.1042). The average number of particles expelled per cough varied widely from patient to patient, ranging from 900 to 302,200 particles/cough while subjects had influenza and 1100 to 308,600 particles/cough after recovery. When the subjects had influenza, an average of 63% of each subject's cough aerosol particle volume in the detection range was in the respirable size fraction (SD 22%), indicating that these particles could reach the alveolar region of the lungs if inhaled by another person. This enhancement in aerosol generation during illness may play an important role in influenza transmission and suggests that a better understanding of this phenomenon is needed to predict the production and dissemination of influenza-laden aerosols by people infected with this virus. [Supplementary materials are available for this article. Go to the publisher's online edition of Journal of Occupational and Environmental Hygiene for the following free supplemental resources: a PDF file of demographic information, influenza test results, and volume and peak flow rate during each cough and a PDF file containing number and size of aerosol particles produced.]

[1]  Michael Gardam,et al.  Transmission of influenza A in human beings. , 2007, The Lancet. Infectious diseases.

[2]  J. Duguid,et al.  The size and the duration of air-carriage of respiratory droplets and droplet-nuclei , 1946, Epidemiology and Infection.

[3]  N. Stilianakis,et al.  Inactivation of influenza A viruses in the environment and modes of transmission: A critical review , 2008, Journal of Infection.

[4]  T. Newsome,et al.  Exhalation of respiratory viruses by breathing, coughing, and talking , 2009, Journal of medical virology.

[5]  William G. Lindsley,et al.  Measurements of Airborne Influenza Virus in Aerosol Particles from Human Coughs , 2010, PloS one.

[6]  M. L. Laucks,et al.  Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles , 2000 .

[7]  E Andres Houseman,et al.  Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. , 2011, Journal of aerosol medicine and pulmonary drug delivery.

[8]  Raymond Tellier,et al.  Review of Aerosol Transmission of Influenza A Virus , 2006, Emerging infectious diseases.

[9]  Benjamin J. Cowling,et al.  Influenza Virus in Human Exhaled Breath: An Observational Study , 2008, PloS one.

[10]  E. Mirgorodskaya,et al.  Effect of airway opening on production of exhaled particles. , 2010, Journal of applied physiology.

[11]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[12]  Ismail Celik,et al.  Measurement of airborne influenza virus in a hospital emergency department. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K. Shine,et al.  Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report , 2009 .

[14]  T. Tumpey,et al.  Influenza A virus transmission: contributing factors and clinical implications , 2010, Expert Reviews in Molecular Medicine.

[15]  William G Lindsley,et al.  Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Rachael M. Jones,et al.  Relative Contributions of Four Exposure Pathways to Influenza Infection Risk , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[17]  Mary-Louise McLaws,et al.  The role of particle size in aerosolised pathogen transmission: A review , 2010, Journal of Infection.

[18]  Raymond Tellier,et al.  Transmission of influenza A in human beings. , 2007, The Lancet. Infectious diseases.

[19]  S. Kato,et al.  Study on transport characteristics of saliva droplets produced by coughing in a calm indoor environment , 2006 .

[20]  Yuguo Li,et al.  Exhaled droplets due to talking and coughing , 2009, Journal of The Royal Society Interface.

[21]  Gerhard Scheuch,et al.  Inhaling to mitigate exhaled bioaerosols. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Hubbard,et al.  Toward Understanding the Risk of Secondary Airborne Infection: Emission of Respirable Pathogens , 2005, Journal of occupational and environmental hygiene.

[23]  Raymond Tellier,et al.  Aerosol transmission of influenza A virus: a review of new studies , 2009, Journal of The Royal Society Interface.